Catherine S. Healey
97 works · 15,273 citations · h-index 47
Top works
- Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
- Genome-wide association study identifies novel breast cancer susceptibility loci
- Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC
- Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours
- A systematic review of genetic polymorphisms and breast cancer risk.
- The Extent of Linkage Disequilibrium in Four Populations with Distinct Demographic Histories
- A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC.
- A polymorphic stop codon in BRCA2
- Genome-wide association study identifies five new breast cancer susceptibility loci
- Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2
- Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants
- Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
- Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer
- Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.
- A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability
- Localisation of the gene for multiple endocrine neoplasia type 2A to a 480 kb region in chromosome band 10q11.2
- Polymorphisms Associated With Circulating Sex Hormone Levels in Postmenopausal Women
- A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer.
- Association of a Common Variant of the CASP8 Gene With Reduced Risk of Breast Cancer
- Effect of germ-line genetic variation on breast cancer survival in a population-based study.